D. Sato's Profile

Role	Title	Level	Year	L/R
🐜	MRI characteristics of neuromyelitis optica spectrum disorder 15 auth. H. Kim, F. Paul, M. Lana-Peixoto, S. Tenembaum, N. Asgari, Jacqueline A Palace, E. Klawiter, D. Sato, J. de Seze, J. Wuerfel, ... B. Banwell, P. Villoslada, A. Saiz, K. Fujihara, Su-Hyun Kim	9	2015	9 🐜
🦁	Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders 15 auth. D. Sato, D. Callegaro, M. Lana-Peixoto, P. Waters, F. Jorge, Toshiyuki Takahashi, I. Nakashima, S. Apóstolos-Pereira, Natália C. Talim, R. Simm, ... A. Lino, T. Misu, M. Leite, M. Aoki, K. Fujihara	9	2014	9 🦁
🐜	Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria 23 auth. B. Banwell, J. Bennett, R. Marignier, H. Kim, F. Brilot, E. Flanagan, S. Ramanathan, P. Waters, S. Tenembaum, J. Graves, ... T. Chitnis, A. Brandt, C. Hemingway, R. Neuteboom, L. Pandit, M. Reindl, A. Saiz, D. Sato, K. Rostásy, Friedemann Paul, S. Pittock, K. Fujihara, Jacqueline Palace	8	2023	8 🐜
🐜	MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy 12 auth. R. Ogawa, I. Nakashima, Toshiyuki Takahashi, K. Kaneko, T. Akaishi, Y. Takai, ... D. Sato, S. Nishiyama, T. Misu, H. Kuroda, M. Aoki, K. Fujihara	8	2017	8 🐜
🐜	MOG cell-based assay detects non-MS patients with inflammatory neurologic disease 16 auth. P. Waters, M. Woodhall, K. O’Connor, M. Reindl, B. Lang, D. Sato, M. Juryńczyk, G. Tackley, J. Rocha, Toshiyuki Takahashi, ... T. Misu, I. Nakashima, Jacqueline A Palace, K. Fujihara, M. Leite, A. Vincent	8	2015	8 🐜
🐜	Myelin-oligodendrocyte glycoprotein antibody-associated disease 41 auth. R. Marignier, Y. Hacohen, Á. Cobo-Calvo, A. Pröbstel, O. Aktas, H. Alexopoulos, Mary Amato, N. Asgari, B. Banwell, J. Bennett, F. Brilot, M. Capobianco, T. Chitnis, O. Ciccarelli, K. Deiva, ... J. Seze, K. Fujihara, A. Jacob, H. Kim, I. Kleiter, H. Lassmann, M. Leite, C. Linington, E. Meinl, Jacqueline Palace, Friedemann Paul, A. Petzold, S. Pittock, M. Reindl, D. Sato, K. Selmaj, A. Siva, B. Stankoff, M. Tintoré, A. Traboulsee, P. Waters, E. Waubant, B. Weinshenker, T. Derfuss, S. Vukusic, Bernhard Hemmer	8	2021	8 🐜
🐬	Neuromyelitis Optica Spectrum Disorders. T. Akaishi, I. Nakashima, D. Sato, Toshiyuki Takahashi, K. Fujihara	7	2017	7 🐬
🐜	Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders 7 auth. A. Jacob, A. McKeon, I. Nakashima, D. Sato, L. Elsone, K. Fujihara, ... J. de Seze	7	2012	7 🐜
🐢	MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder 7 auth. G. D. dos Passos, L. Oliveira, Bruna Klein da Costa, S. Apóstolos-Pereira, D. Callegaro, K. Fujihara, ... D. Sato	7	2018	7 🐢
🐜	CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications 17 auth. K. Kaneko, D. Sato, I. Nakashima, R. Ogawa, T. Akaishi, Y. Takai, S. Nishiyama, Toshiyuki Takahashi, T. Misu, H. Kuroda, ... Satoru Tanaka, K. Nomura, Yuji Hashimoto, D. Callegaro, L. Steinman, K. Fujihara, M. Aoki	7	2018	7 🐜
🐜	MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study 14 auth. T. Akaishi, D. Sato, I. Nakashima, Takayuki Takeshita, Toshiyuki Takahashi, H. Doi, Kazuhiro Kurosawa, K. Kaneko, H. Kuroda, S. Nishiyama, ... T. Misu, T. Nakazawa, K. Fujihara, M. Aoki	7	2015	7 🐜